Risky business: Challenges in vaccine risk communication

被引:131
作者
Ball, LK
Evans, G
Bostrom, A
机构
[1] US FDA, Ctr Biol Evaluat & Res, Off Vaccines Res & Review, Rockville, MD 20852 USA
[2] US Hlth Resources & Serv Adm, Natl Vaccine Injury Compensat Program, Dept Hlth & Human Serv, Rockville, MD 20857 USA
[3] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA
关键词
D O I
10.1542/peds.101.3.453
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
[No abstract available]
引用
收藏
页码:453 / 458
页数:6
相关论文
共 52 条
  • [11] COLLEY F, 1994, J MANIP PHYSIOL THER, V17, P584
  • [12] COULTER HL, 1986, SHOT DARK PARENTS GU
  • [13] Covello V.T., 1988, RISK COMMUNICATION R
  • [14] Covello VT, 1991, ACCEPTABLE EVIDENCE, P66
  • [15] DAWSON NV, 1993, CLIN CHEM, V39, P1468
  • [16] Evans G, 1997, RISK COMMUNICATION V
  • [17] RISK PERCEPTION AND COMMUNICATION
    FISCHHOFF, B
    BOSTROM, A
    QUADREL, MJ
    [J]. ANNUAL REVIEW OF PUBLIC HEALTH, 1993, 14 : 183 - 203
  • [18] Fischhoff B., 1983, The analysis of actual versusperceived risks, P235, DOI [10.1007/978-1-4613-3760-7_16, DOI 10.1007/978-1-4613-3760-7_16]
  • [19] Safety of vaccinations - Miss America, the media, and public health
    Freed, GL
    Katz, SL
    Clark, SJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (23): : 1869 - 1872
  • [20] GOLDSMITH MF, 1992, JAMA-J AM MED ASSOC, V267, P2005